Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Income from Continuing Operations (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Income from Continuing Operations for 16 consecutive years, with 1308000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Income from Continuing Operations rose 126.04% to 1308000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 1772000.0, a 110.08% increase, with the full-year FY2024 number at 16428000.0, down 2589.09% from a year prior.
  • Income from Continuing Operations was 1308000.0 for Q3 2025 at Xtant Medical Holdings, down from 3550000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 9231000.0 in Q3 2023 to a low of 5024000.0 in Q3 2024.
  • A 5-year average of 1278052.63 and a median of 2190000.0 in 2023 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: crashed 7531.03% in 2022, then soared 492.31% in 2023.
  • Xtant Medical Holdings' Income from Continuing Operations stood at 2377000.0 in 2021, then increased by 7.03% to 2210000.0 in 2022, then tumbled by 94.71% to 4303000.0 in 2023, then grew by 26.93% to 3144000.0 in 2024, then skyrocketed by 141.6% to 1308000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Income from Continuing Operations are 1308000.0 (Q3 2025), 3550000.0 (Q2 2025), and 58000.0 (Q1 2025).